BD has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush Prefilled Flush Syringes at its US facility.

The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.

Regulatory and supply chain pressures place scaling medical device companies under strain. Expert partners can help ease these pain points.

To realise the potential of medical device data and maintain security protocols in a more connected medtech reality, network architecture must evolve.

Baxter’s share price declined by almost 23% on 31 July following the disclosure of disappointing Q2 2025 results that prompted the company to trim its 2025 profit outlook.